HIV subtype influences HLA-B*07:02-associated HIV disease outcome

AIDS Research and Human Retroviruses

Volumn 30, Issue 5, 2014, Pages 468-475

  Kløverpris, Henrik N ^a,b,c   Adland, Emily ^a   Koyanagi, Madoka ^d   Stryhn, Anette ^b   Harndahl, Mikkel ^b   Matthews, Philippa C ^a   Shapiro, Roger ^e   Walker, Bruce D ^f,g,h   Ndung'U, Thumbi ^c,f,g,i   Brander, Christian ^j,k   Takiguchi, Masafumi ^d   Buus, Søren ^b   Goulder, Philip ^a,f,g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d KUMAMOTO UNIVERSITY   (Japan)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g HARVARD UNIVERSITY   (United States)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

ⁱ MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^j HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^k INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA B ANTIGEN; HLA B7 ANTIGEN; HLA-B*07:02 ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; ADULT; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; EPITOPES, T-LYMPHOCYTE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOTYPE; HIV INFECTIONS; HIV-1; HLA-B7 ANTIGEN; HUMANS; POLYMORPHISM, GENETIC;

EID: 84899828480     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0197     Document Type: Article

References (41)

1. Fellay J, Ge D, Shianna KV, et al.: Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009;5:e1000791
2. Fellay J, Shianna KV, Ge D, et al.: A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317:944-947
3. Pereyra F, Jia X, McLaren PJ, et al.: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010;330:1551-1557
4. O'Brien SJ, Gao X, and Carrington M: HLA and AIDS: A cautionary tale. Trends Mol Med 2001;7:379-381
5. Kiepiela P, Leslie AJ, Honeyborne I, et al.: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769-775
6. Leslie A, Matthews PC, Listgarten J, et al.: Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010;84:9879-9888
7. Matthews PC, Prendergast A, Leslie A, et al.: Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 2008;82:8548-8559
8. Rousseau CM, Daniels MG, Carlson JM, et al.: HLA class-I driven evolution of human immunodeficiency virus type 1 subtype C proteome: Immune escape and viral load. J Virol 2008;82:6434-6446
9. Goulder PJ and Walker BD: HIV and HLA class I: An evolving relationship. Immunity 2012;37:426-440
10. Kiepiela P, Ngumbela K, Thobakgale C, et al.: CD8+ T cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007;13:46-53
11. Zuniga R, Lucchetti A, Galvan P, et al.: Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 2006;80:3122-3125
12. Altfeld M, Addo MM, Rosenberg ES, et al.: Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003;17:2581-2591
13. Goulder PJ, Phillips RE, Colbert RA, et al.: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-217
14. Kloverpris HN, Stryhn A, Harndahl M, et al.: HLA-B57 micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. J Virol 2012;86:919-929
15. Leslie AJ, Pfafferott KJ, Chetty P, et al.: HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004;10:282-289
16. Crawford H, Lumm W, Leslie A, et al.: Evolution of HLAB5703 HIV-1 escape mutations in HLA-B5703-positive individuals and their transmission recipients. J Exp Med 2009;206:909-921
17. Crawford H, Prado JG, Leslie A, et al.: Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol 2007;81:8346-8351
18. Martinez-Picado J, Prado JG, Fry EE, et al.: Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 2006;80: 3617-3623
19. Schneidewind A, Brockman MA, Yang R, et al.: Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 2007;81:12382-12393
20. Flores-Villanueva PO, Yunis EJ, Delgado JC, et al.: Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA 2001;98:5140-5145
21. Martin MP, Gao X, Lee JH, et al.: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002;31:429-434
22. Martin MP, Qi Y, Gao X, et al.: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007;39:733-740
23. Marsh SGE, Parham P, and Barber LD: The HLA Facts Book. Academic Press, London, 2000
24. Kosmrlj A, Read EL, Qi Y, et al.: Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 2010;465:350-354
25. Huang J, Goedert JJ, Sundberg EJ, et al.: HLA-B35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J Exp Med 2009;206:2959-2966
26. Lazaryan A, Song W, Lobashevsky E, et al.: The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum Immunol 2011;72: 312-318
27. Matthews PC, Koyanagi M, Kloverpris HN, et al.: Differential clade-specific HLA-B3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope. J Virol 2012;86:12643-12654
28. Apps R, Qi Y, Carlson JM, et al.: Influence of HLA-C expression level on HIV control. Science 2013;340:87-91
29. Itoh Y, Mizuki N, Shimada T, et al.: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOPLuminex method in the Japanese population. Immunogenetics 2005;57:717-729
30. Kawashima Y, Pfafferott K, Frater J, et al.: Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009;458:641-645
31. Llano A, Frahm N, and Brander C: How to optimally define optimal cytotoxic T lymphocyte epitopes in HIV infection? HIV Molecular Immunology Database, 2009
32. Carlson JM, Brumme ZL, Rousseau CM, et al.: Phylogenetic dependency networks: Inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput Biol 2008; 4:e1000225
33. Leisner C, Loeth N, Lamberth K, et al.: One-pot, mix-andread peptide-MHC tetramers. PLoS One 2008;3:e1678
34. Harndahl M, Justesen S, Lamberth K, Roder G, Nielsen M, and Buus S: Peptide binding to HLA class I molecules: Homogenous, high-throughput screening, and affinity assays. J Biomol Screen 2009;14:173-180
35. Harndahl M, Rasmussen M, Roder G, and Buus S: Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. J Immunol Methods 2011;374:5-12
36. Carlson JM, Brumme CJ, Martin E, et al.: Correlates of protective cellular immunity revealed by analysis of populationlevel immune escape pathways in HIV-1. J Virol 2012;86: 13202-13216
37. Carlson JM, Listgarten J, Pfeifer N, et al.: Widespread impact of HLA restriction on immune control and escape pathways of HIV-1. J Virol 2012;86:5230-5243
38. Listgarten J, Brumme Z, Kadie C, et al.: Statistical resolution of ambiguous HLA typing data. PLoS Comput Biol 2008; 4:e1000016
39. Frahm N, Korber BT, Adams CM, et al.: Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004;78:2187-2200
40. Frahm N, Kiepiela P, Adams S, et al.: Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol 2006;7:173-178
41. Mothe B, Llano A, Ibarrondo J, et al.: Definition of the viral targets of protective HIV-1-specific T cell responses. J Transl Med 2011;9:208.